Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs
Published in: Drugs 11/2007

01-08-2007 | Therapy in Practice

Long-Acting Injectable Risperidone for the Treatment of Schizophrenia

Clinical Perspectives

Author: Dr Hans-Jürgen Möller

Published in: Drugs | Issue 11/2007

Login to get access
Metadata
Title
Long-Acting Injectable Risperidone for the Treatment of Schizophrenia
Clinical Perspectives
Author
Dr Hans-Jürgen Möller
Publication date
01-08-2007
Publisher
Springer International Publishing
Published in
Drugs / Issue 11/2007
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.2165/00003495-200767110-00003

Other articles of this Issue 11/2007

Drugs 11/2007 Go to the issue

Adis Drug Evaluation

Rasagiline

Review Article

Invasive Aspergillosis

Correspondence

The Author’s Reply

Adis Drug Evaluation

Fludarabine

Current Opinion

Proton-Pump Inhibitor Therapy in Patients with Gastro-Oesophageal Reflux Disease

Correspondence

Premature Ejaculation